Company Name
Shanghai Kehua Bio-Engineering Co.Ltd.
Listed Exchange
SZ Stock Exchange
Legal Representative
Zhichao Ma
Accounting Firm
Lixin Certified Public Accountants (special general partnership)
Securities Representative
Xinglong Chen
Legal Counsel
Guohao Law Group (Shanghai) Firm
Office Address
1189 Qinzhou North Road, Xuhui District, Shanghai
Registered Address
1189 Qinzhou North Road, Xuhui District, Shanghai
Business License
310000000000260
Business
Research, production and operation of biochemical reagents, clinical diagnostic reagents, medical devices, veterinary injections, biochemical reagent testing tools, genetically-engineered drugs, microbiological environmentally friendly products, leasing of own equipment and related technical services, and is engaged in the import and export of goods and technology import and export business (except for goods and technology restricted to or prohibited by the country).
Description
The company was founded in 1981 and listed on the small and medium board of the Shenzhen Stock Exchange in 2004 (stock code: 002022.SZ). It is an in vitro diagnostic company integrating R&D, production and sales, with rich production experience and a complete line of medical diagnostic products. Headquartered in Shanghai, it has R&D and production bases in Italy, Shenzhen, Xi'an, Suzhou and other countries and regions, and currently employs nearly 2,000 people. The company's main business is R&D, production and sales of in vitro diagnostic reagents and medical testing instruments. The company's own products cover the three fields of molecular diagnosis, biochemical diagnosis, and immune diagnosis. It has more than 200 reagents and instrument products, more than 80 domestic products that have been CE certified by the European Union, and some products have also been certified and approved by the United States, South Korea and other countries. At the same time, the company's Italian subsidiary TGS owns more than 80 CE certified products. Kehua brand products have been exported to more than 30 countries and regions overseas. It has significant product line competitive advantages in the domestic in vitro clinical diagnosis industry and is in a leading position in the industry. Corporate honors: high-tech enterprises, Shanghai's top 100 manufacturing enterprises in 2022, China's top 100 innovative small and medium-sized enterprises, famous trademarks in Shanghai, etc.
